The National Strategy for Countering the Proliferation of Biological Threats has launched an effort to enable biosurveillance of world health which would enable recognition of emerging pandemics, thus saving lives and strengthening national security.
Brookline, MA (PRWEB) April 21, 2011
The Knowledge Foundation has announced that the keynote address for the 18th Biodetection Technologies conference will be delivered by Dr. Peter Emanuel, BioScience Division Chief at the U.S. Army Edgewood Chemical Biological Center, on June 24, 2011 at the Marriott Wardman Park in Washington, DC.
The Joint Program Executive Office for Chemical and Biological Defense and the Defense Threat Reduction Agency/Joint Science and Technology Office tasked the U.S. Army Edgewood Chemical Biological Center and Johns Hopkins Applied Physics Laboratory to compile a technology survey on biosurveillance hardware systems which have applicability in assessing human exposure to chemical, biological, and radiological agents. This survey targeted information on commercially available and maturing diagnostic and identification/detection products that have technology readiness levels from TRL 4 to TRL 9 which does not include basic research concepts. Dr. Emanuel will discuss what this effort found and what it may mean for the interagency needs for purchasing technologies in the coming years.
Biodetection Technologies is an internationally recognized event for experts in detection and identification of biological and chemical threats and will explore the latest R&D developments as well as ready-to-market systems for major biothreat detection, identification, and analysis both in the field and at the point-of-care. Topics to be explored when world leaders convene for this high-level symposium include:
- Technological advances in detection & identification of biological threats
- Point-of-care applications for pathogen, virus & threat detection & identification
- Challenges for rapid, early, specific & sensitive detection
- Role of nanotechnology and system miniaturization - MEMS & bioMEMS
- Use of biochip technology - micro- & nanofluidics
- Bioinformatics for biodefense
- Field-deployable devices: portability/compatibility/reliability/scalability
- Reagentless vs. reagent biodetection systems
- Non-PCR vs. PCR-based detection techniques
- David Almassian, Tetracore, Inc.
- Amy L. Altman, PhD, Luminex Corporation
- Marie Binet, EDF
- Amos Danielli, PhD, Washington University in St. Louis
- Peter Emanuel, PhD, US Army Edgewood Chemical Biological Center
- Matthias Frank, PhD, Lawrence Livermore National Laboratory
- Julie Fruetel, PhD, Sandia National Laboratories
- Andrei Gindilis, PhD, SHARP Laboratories of America
- Robert Haushalter, PhD, Parallel Synthesis Technologies
- Ryan Kim, PhD, National Center for Genome Resources
- Steve Jackinsky, Wi, Inc.
- Kiyoshi Nokihara, DPharmSci, HiPep Laboratories
- Natasha Paul, PhD, TriLink BioTechnologies, Inc.
- Dinakar Ramadurai, PhD, Episensors, Inc.
- Ze'ev Russak, Azure PCR Limited
- Robert F. Standaert, PhD, Oak Ridge National Laboratory
- Yi-Wei Tang, MD, PhD, Vanderbilt University Medical Center
- Willy A. Valdivia-Granda, PhD, Orion Integrated Biosciences Inc.
- Francisco Veas, PhD, University Montpellier 1
- Felix von Stetten, PhD, University of Freiburg
- Reinhold Wimberger-Friedl, PhD, Philips Research
About The Knowledge Foundation
The Knowledge Foundation integrates scientific ingenuity and real-world applications by fostering collaborative research at the rapidly changing intersection of science and business. Known for providing members of its Technology Commercialization Alliance with direct and unbiased state-of-the-art scientific information, the Knowledge Foundation is uniquely qualified to provide wider exposure for important developments in the emerging fields of alternative energy, nanotechnology, and chemical/biological detection technologies.
# # #